Increasing prescription of drugs for secondary prevention of myocardial infarction. Authors' recommendations are too restrictive

BMJ. 1996 Jan 27;312(7025):252. doi: 10.1136/bmj.312.7025.252a.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use*
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Aspirin / therapeutic use*
  • Drug Prescriptions
  • Humans
  • Myocardial Infarction / prevention & control*

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Aspirin